Navigation Links
Catalent to Launch Innovative Fish Oil Supplement Product at Vitafoods Europe

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to launch a new product, Fish Oil Thin Shell EasyBurst® Chewables, at the upcoming Vitafoods Europe Conference, to be held at the Geneva Palexpo, Switzerland, on May 9 – 11, 2017.

This innovative product overcomes many of the challenges associated with fish oil supplements, including large capsule size, odors, and unpleasant aftertaste, offering consumers a smaller, chewable dosage form that does not require water. The oil component of the product is concentrated, and each capsule is capable of delivering 200 mg of fish oil providing 110 mg or more of Omega-3 (with at least 80 mg of DHA and 12 mg or more of EPA). An alternative to standard capsules and chewable gummies, Fish Oil Thin Shell EasyBurst Chewables are ideal for consumers who have difficulty swallowing, including children and the elderly.

At the Conference, Catalent will be participating in the exhibitor speaking sessions: Ms. Claudia Valla, Product Development Adviser, Catalent Consumer Health will be presenting on May 11 at 10:30 a.m., on the subject of “Learn How Vegetarian Capsules Can Address Needs of the Natural Consumer,” where she will discuss how the market can adapt to the growing demands of consumers who demand vegetarian products and innovative dosage form solutions.

Ms. Valla will also be contributing to the Omega-3 Resource Center at the Conference, with a series of presentations as follows:

  • Tuesday May 9, at 1:30 p.m., “Omega-3 Plant Based Trends and Opportunities for Innovation;”
  • Tuesday May 9, at 3:30 p.m., “Oxidation and Omega-3s: Addressing the Challenges;”
  • Wednesday May 10, at 1:00 p.m., “New Innovation Products for the Omega-3 Market.”

Additionally, Catalent’s Vice President and General Manager of Nutritional Softgels, Mr. Timothy Doran, will be speaking at one of the keynote panel discussions. On Thursday, May 11, at 11:30, Mr. Doran will join other industry experts for a session entitled “Accountability: Setting the standard and raising the bar in contract manufacturing,” where business practices and outsourcing partnerships will be discussed.

For more information on the Vitafoods Europe Conference, visit Catalent/Vitafoods and to arrange a meeting with Catalent executives at the event, contact Richard Kerns at NEPR - richard(at)nepr(dot)eu.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit

More products. Better treatments. Reliably supplied.™

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Challenges and Strategies to Automate Potency Assays to be Discussed by Catalent Expert at Upcoming CASSS Bioassays Symposium
2. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
3. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
4. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
5. Catalent to Host Workshop with Leading Biologics Experts on Advanced Protein Development and Delivery at Upcoming Drug Delivery Partnerships Conference
6. Innovative Strategies for the Development of Lipid-based Oral Medicines to be Presented by Catalent and Gattefossé at Forthcoming Workshop
7. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
8. Catalent to Develop Softgel Capsules for JOT’s Leading Orphan Disease Candidates
9. Catalent Biologics Collaborates with PATH Malaria Vaccine Initiative to Create Antibodies for Malaria Vaccine Research and Development
10. Catalent Becomes First CDMO to Join Pharmaceutical Supply Chain Initiative: Helps Shape Better Supply Chain to Pharmaceutical and Healthcare Industries
11. The Challenges and Opportunities for Cannabis-Based Therapeutics: Catalent to Present at Upcoming Industry Conference
Post Your Comments:
(Date:6/24/2020)... , ... June 24, 2020 , ... At Allerio we ... connectivity for telemedicine and remote communications. We knew it had to be portable, it ... and that it just has to work. , We are proud to announce that ...
(Date:6/24/2020)... Ga. (PRWEB) , ... June 24, 2020 , ... ... and population health management, today announced that Wexford Physician Hospital Organization (PHO) has ... quality and cost goals within the framework of value-based care. Use of Population ...
(Date:6/24/2020)... ... 2020 , ... Skyroam , the developer of patented virtual SIM (vSIM) ... leading provider of enterprise software for testing laboratories, in which its Skyroam Solis Lite ... Disease Surveillance Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global ...
(Date:6/23/2020)... ... 23, 2020 , ... Oak Street Health, a network of primary care centers ... expansion in 2020 with the company’s first centers in New York and Mississippi anticipated ... N.Y., and a new center in Jackson, Miss. , “The planned opening of ...
(Date:6/23/2020)... ... 2020 , ... Rritual , the premium brand in the emerging functional ... the President of North America’s leading mushroom adaptogens company. , Dr. Hart has ... his own family medicine clinic in London, Ontario, Canada where he regularly integrates plant-based ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... Lighthouse ... Applied Behavioral Analysis ("ABA") therapy, today announced the acquisition of Autism Therapy ... This acquisition will make Lighthouse Autism Center one of the largest ABA ...
(Date:6/23/2020)... ... June 23, 2020 , ... Construction ... 2020 which now features a greatly enlarged and enhanced medical facility. Penetron ... structures, water tanks, and rooftop garden. , Part of the Bangkok Chain Hospital ...
(Date:6/19/2020)... ... June 19, 2020 , ... Food Equality Initiative ... diagnosed with food allergies and celiac disease announced the first of the “ For ... webinar is scheduled for Friday, June 19, 2020, from 11:00, am EST - 12:00 ...
Breaking Medicine Technology: